Protocol | NRG BN003 |
---|---|
Cancer Type: | MENINGIOMA |
Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | CCTG MA.39 Adjuvant |
---|---|
Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Protocol | NRG BR007 |
---|---|
Cancer Type: | Stage 1, Hormone Sensitive Her2 negative |
Fast Facts |
Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage 1, Hormone Sensitive HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer (DEBRA) De-Escalation of Breast Radiation
Protocol | NRG BR008 |
---|---|
Cancer Type: | Breast |
Fast Facts |
NRG-BR008, "A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer” (HERO)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2183 |
---|---|
Cancer Type: | Esophageal and Gastric Adenocarcinoma |
Fast Facts |
A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic Esophageal and Gastric Adenocarcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1802 |
---|---|
Cancer Type: | Metastatic Prostate Cancer |
Fast Facts |
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Protocol | NRG GU009 |
---|---|
Cancer Type: | HIGH RISK PROSTATE CANCER |
Fast Facts |
PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
Protocol | NRG GU010 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
NRG-GU010 - Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Protocol | NRG GU011 |
---|---|
Cancer Type: | Prostate |
Fast Facts |
NRG-GU011, A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)
Protocol | NRG GU013 |
---|---|
Cancer Type: | Prostate |
Fast Facts |
NRG-GU013, The Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA3132 |
---|---|
Cancer Type: | Head and Neck |
Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Protocol | RTOG 1216 |
---|---|
Cancer Type: | Pathologic High-Risk Squamous Cell Cancer |
Fast Facts |
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A082002 |
---|---|
Cancer Type: | Non-Small Cell Lung Cancer |
Fast Facts |
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Protocol | NRG LU008 |
---|---|
Cancer Type: | Lung Cancer |
Fast Facts |
Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1827 |
---|---|
Cancer Type: | Small Cell Lung |
Fast Facts |
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Protocol | NRG LU007 |
---|---|
Cancer Type: | ES-SCLC |
Fast Facts |
RAndomized Phase II/III Trial Of Consolidation Radiation + Immuno-therapy for ES-SCLC: RAPTOR trial
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.